George Dennis Bolton - 31 Dec 2024 Form 5 Insider Report for BLUE BIOFUELS, INC. (BIOF)

Reporting relationship: Director
Issuer ticker: BIOF
Reported as of: 31 Dec 2024
Net transaction value: $0
SEC form: 5
Accepted by SEC: 10 Jan 2025, 06:12:43 UTC
Prior SEC filing: 02 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ George Bolton

Key filing fact

George Dennis Bolton filed Form 5 for BLUE BIOFUELS, INC. (BIOF) on 10 Jan 2025.

Key facts

This page summarizes George Dennis Bolton's Form 5 filing for BLUE BIOFUELS, INC. (BIOF).
10 reported transactions and 10 derivative rows are listed below.
Accepted by SEC: 10 Jan 2025, 06:12.

Change

Previous filing in this sequence was filed on 02 Mar 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIOF transaction Derivative

Call Option

Award

Transaction value: $0
Shares: +100,000
Change %: +20%
Price: $0.000000
Shares after: 600,000
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Stock
Underlying amount: 100,000
Exercise price: $0.1900

BIOF transaction Derivative

Call Option

Award

Transaction value: $0
Shares: +100,000
Change %: +17%
Price: $0.000000
Shares after: 700,000
Date: 01 Jun 2024
Ownership: Direct
Underlying class: Stock
Underlying amount: 100,000
Exercise price: $0.1900

BIOF transaction Derivative

Call Option

Award

Transaction value: $0
Shares: +100,000
Change %: +14%
Price: $0.000000
Shares after: 800,000
Date: 01 Sep 2024
Ownership: Direct
Underlying class: Stock
Underlying amount: 100,000
Exercise price: $0.1900

BIOF transaction Derivative

Call Option

Award

Transaction value: $0
Shares: +100,000
Change %: +12%
Price: $0.000000
Shares after: 900,000
Date: 01 Dec 2024
Ownership: Direct
Underlying class: Stock
Underlying amount: 100,000
Exercise price: $0.1900

BIOF transaction Derivative

Call Option

Award

Transaction value: $0
Shares: +231,667
Change %: +26%
Price: $0.000000
Shares after: 1,131,667
Date: 08 Jan 2025
Ownership: Direct
Underlying class: Stock
Underlying amount: 231,667
Exercise price: $0.1100

BIOF transaction Derivative

Call Option

Award

Transaction value: $0
Shares: +100,000
Change %: +8.8%
Price: $0.000000
Shares after: 1,231,667
Date: 08 Jan 2025
Ownership: Direct
Underlying class: Stock
Underlying amount: 100,000
Exercise price: $0.1900

BIOF transaction Derivative

Call Option

Award

Transaction value: $0
Shares: +500,000
Change %: +41%
Price: $0.000000
Shares after: 1,731,667
Date: 02 Jan 2025
Ownership: Direct
Underlying class: Stock
Underlying amount: 500,000
Exercise price: $0.2000
Footnotes: F1

BIOF transaction Derivative

Call Option

Award

Transaction value: $0
Shares: +289,583
Change %: +17%
Price: $0.000000
Shares after: 2,021,250
Date: 02 Jan 2025
Ownership: Direct
Underlying class: Stock
Underlying amount: 289,583
Exercise price: $0.1100
Footnotes: F1

BIOF transaction Derivative

Call Option

Award

Transaction value: $0
Shares: +1,000,000
Change %: +49%
Price: $0.000000
Shares after: 3,021,250
Date: 02 Jan 2025
Ownership: Direct
Underlying class: Stock
Underlying amount: 1,000,000
Exercise price: $0.1900
Footnotes: F2

BIOF transaction Derivative

Call Option

Award

Transaction value: $0
Shares: +579,167
Change %: +19%
Price: $0.000000
Shares after: 3,600,417
Date: 02 Jan 2025
Ownership: Direct
Underlying class: Stock
Underlying amount: 579,167
Exercise price: $0.1100
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The options above with a (1) exercisable date vest upon the sooner of the production of biofuels by the Company or the uplisting of the Company's common stock to a major exchange.

Footnote F2

The options above with a (2) exercisable date vest upon the obtainment of an offtake agreement for the Company by Reporting Person.